Friday 6 November 2026 Export INSM’s income statement to Excel — free account

Insmed, Inc.

INSM Healthcare Biotechnology

Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.

Revenue: +268.4%
EPS: +73.8%
Free cash flow: +81.1%
Total debt: +0.27%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

114.36 5.60 +5.15%

Follow INSM

Alert me

Market cap: $23.9B
P/E: 0.0×
Fwd P/E: −64.6×
Dividend yield: —
F-score: 4/9
Altman Z: 9.29
Beneish M: −1.90
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insmed, Inc. (INSM) Current ratio

Alert me on Current ratio

Insmed, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.9×, down 1.0× from fiscal 2025 (3.8×). Over the past ten years it has ranged from 3.8× (fiscal 2025) to 12.9× (fiscal 2015) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/INSM/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Insmed, Inc. current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/INSM/metrics/current-ratio">Insmed, Inc. (INSM) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	3.8×	(29.79%)
FY2024	5.5×	32.37%
FY2023	4.1×	(38.48%)
FY2022	6.7×	8.09%
FY2021	6.2×	18.12%
FY2020	5.2×	(19.50%)
FY2019	6.5×	0.07%
FY2018	6.5×	(25.37%)
FY2017	8.7×	44.94%
FY2016	6.0×	(53.52%)

Period	Current ratio	Change
Sep 2026	2.9×	(23.19%)
Jun 2026	3.7×	(16.66%)
Mar 2026	4.5×	16.77%
Dec 2025	3.8×	(17.36%)
43 more quarters	Free account

Against its own ten years

Low 3.8× High 12.9×

Ten-year median 6.2×

Current reading's percentile 9

Company	Current ratio
ROIV Roivant Sciences Ltd. compare	16.7×
BNTX BioNTech SE Sponsored ADR compare	8.6×
INCY Incyte Corporation compare	3.8×
EXEL Exelixis, Inc. compare	3.2×
ASND Ascendis Pharma A/S compare	3.0×
INSM Insmed, Inc.	2.9×
ALNY Alnylam Pharmaceuticals, Inc. compare	2.5×
GMAB Genmab A/S Sponsored ADR compare	2.5×
BBIO BridgeBio Pharma, Inc. compare	2.1×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Insmed, Inc. (INSM) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on INSM

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on INSM

Stockrow Weekly